Lifeboat Foundation

https://www.forbes.com/sites/johnkoetsier/2020/11/20/this-2-…f7a547a57c to Nate Storey, the future of farms is vertical. It’s also indoors, can be placed anywhere on the planet, is heavily integrated with robots and AI, and produces better fruits and vegetables while using 95% less water and 99% less land.

95% less water. 99% less land. 400X more yield.

This week, a German company deployed 3D printing technology to construct a new residential block, which is set to become the largest printed apartment building in Europe.

Threat actors are looking for API tokens, passwords, and database logins usually stored in ENV files.

“We are going backwards in time,” Prof. Shai Efrati said.

Does the real future of Space exploration lie with enlightened private entrepreneurs such as Bezos & Musk or do national agencies still have a part to play? https://www.nytimes.com/2020/10/13/science/

Blue Origin’s New Shepard rocket hasn’t flown space tourists yet, but it has found a business niche with NASA and private science experiments.

https://www.youtube.com/watch?v=ICGirHAO6T4&feature=youtu.be

A bit of a personal post, but it is very dear to me. Please share to everyone you know (especially to a SpaceX recruiter):

In today’s special video, I talk about why I want to apply to SpaceX as an associate buyer. This job application is very special to me because SpaceX has been my dream company ever since highschool. As such, if you find this video worthy, please share (especially to any SpaceX recruiters).

Continue reading “Why I Want to Apply to SpaceX” »

The work was conducted in the laboratory of Dan Peer, PhD, VP for R&D and Head of the Laboratory of Precision Nanomedicine at the Shmunis School of Biomedicine and Cancer Research at TAU. The research was conducted by Daniel Rosenblum, PhD, together with PhD student Anna Gutkin and colleagues in Peer’s laboratory and other collaborators.

The study “CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy” appears in Science Advances.

“Harnessing CRISPR-Cas9 technology for cancer therapeutics has been hampered by low editing efficiency in tumors and potential toxicity of existing delivery systems. Here, we describe a safe and efficient lipid nanoparticle (LNP) for the delivery of Cas9 mRNA and sgRNAs that use a novel amino-ionizable lipid,” write the investigators.

Think of something as simple as “smile” and the system would generate a matching headshot.